Investor Relations

IR Home

Recent Newsmore >
02/07/18
ConforMIS Reports Fourth Quarter and the Year Ended 2017 Financial Results; Reiterates 2018 Financial Guidance
BILLERICA, Mass., Feb. 07, 2018 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are customized to fit each patient's unique anatomy, announced today financial results for the fourth quarter and the year ended December 31, 2017. Q4 Summary Total revenue of $20.8 million, down 4% year-over-year on a reported basis and 5% on a... 
01/25/18
ConforMIS Announces Pricing of Public Offering of Common Stock
BILLERICA, Mass., Jan. 25, 2018 (GLOBE NEWSWIRE) -- ConforMIS,  Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are customized to fit each patient's unique anatomy, today announced the pricing of an underwritten public offering of 13,333,333 shares of its common stock at a public offering price of $1.50 per share, before underwriting discounts, raising $20 milli... 
Upcoming Eventsmore >
There are currently no events scheduled.
IR Contact
Oksana Bradley
Investor Relations
Phone: (781) 374-5598
E-mail: ir@conformis.com

Media Contacts
Bill Berry
Berry & Company Public Relations
Phone: (212) 253-8881
E-mail: Bberry@berrypr.com

Lynn Granito
Berry & Company Public Relations
Phone: (212) 253-8881
E-mail: Lgranito@berrypr.com
Data provided by Nasdaq. Minimum 15 minutes delayed.